Measuring the quality of melanoma surgery – Highlighting issues with standardization and quality assurance of care in surgical oncology

Pasquali, Sandro; Sommariva, Antonio; Spillane, Andrew J.; Bilimoria, Karl Y.; Rossi, Carlo Riccardo

doi:10.1016/j.ejso.2016.06.397

Cited by 23 publications

(18 citation statements)

References 94 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…With rapid progress in new treatments, long-term loco-regional control and standardised surgical techniques are now becoming imperative (Pasquali et al, 2017).…”

Section: Treatmentmentioning

confidence: 99%

“…A general paper on standardization and evolution of quality indicators for melanoma surgery was published in 2017 (Pasquali et al, 2017), and includes quality assurance examples from the Melanoma Institute Australia, the Italian Melanoma Intergroup and the American College of Surgeons. The paper has extensive references on the development of surgical quality for melanoma.…”

Section: National Quality Examplesmentioning

confidence: 99%

See 1 more Smart Citation

ECCO essential requirements for quality cancer care for melanoma: Defining how to organise care

Wouters

2018

European Journal of Surgical Oncology

View full text Add to dashboard Cite

“…With rapid progress in new treatments, long-term loco-regional control and standardised surgical techniques are now becoming imperative (Pasquali et al, 2017).…”

Section: Treatmentmentioning

confidence: 99%

Section: National Quality Examplesmentioning

confidence: 99%

ECCO essential requirements for quality cancer care for melanoma: Defining how to organise care

Wouters

2018

European Journal of Surgical Oncology

View full text Add to dashboard Cite

“…While quality of surgery has been already investigated in other cancers, the use of measures of quality assurance for surgery is less established in melanoma (6). Available literature offers substantial heterogeneity in surgical procedures among melanoma centers or even among surgeons within the same center (7). Although adherence to current standards is part of a quality assurance process, the spreading of clinical practice guidelines is not su cient per se to warrant homogeneity and quality of surgical treatment (8).…”

Section: Introductionmentioning

confidence: 99%

The Surgical Treatment of Non-Metastatic Melanoma in a Multicenter Registry: A Retrospective Cohort Quality Improvement Study to Reduce the Morbidity Rates

Fiore¹,

Mocellin²,

Rastrelli³

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: Reproducible, high-quality surgery is a key point in the management of cancer patients. Quality indicators for surgical treatment of melanoma has been presented with benchmarks but data on morbidity are still limited. This study presents the quality indicators on morbidity after surgical treatment for non-metastatic skin melanoma in an Italian registry.Methods: Data were extracted from the Central National Melanoma Registry (CNMR) promoted by the Italian Melanoma Intergroup (IMI). All surgical procedures (WE, SNLB or LFND) for non-metastatic skin melanoma between January 2011 and February 2017 were evaluated for inclusion in the study. Only centers with adequate completeness of information (>80%) were included in the study. Short-term complications (wound infection, dehiscence, skin graft failure and seroma) were investigated.Results: Wound infection rate was 1.1% (0.4% to 2.7%) in WE, 1.3% (0.7% to 2.5%) in SLNB and 4.1% (2.1% to 8.0%) in LFND. Wound dehiscence rate was 2.0% (0.8% to 5.1%) in WE, 0.9% (0.2% to 3.0%) in SLNB and 2.8% (0.9% to 8.6%) in LFND. Seroma rate was 4.2% (1.5% to 11.1%) in SLNB and 15.1% (4.6% to 39.9%) in LFND. Unreliable information was found on skin graft failure.Conclusions: Our findings contribute to available literature in setting up the recommended standards for melanoma centers, thus improving the quality of surgery offered to patients. A consensus on the core issues around surgical morbidity is needed to provide practical guidance on morbidity prevention and management.

show abstract

“…When a standardized surgical procedure is established, a cyclic audit (including collection, analysis and feedback of both procedural and outcome data) allows for monitoring and improving the quality of surgery. However, cancer surgery is not always standardized, thus limiting the application of such approach (6).…”

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

The surgical treatment of non metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): a retrospective cohort quality improvement study to reduce the morbidity rates

Vecchiato

Mocellin

Fiore

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: Reproducible, high-quality surgery is a key point in the management of cancer patients. Quality indicators for surgical treatment of melanoma has been presented with benchmarks but data on morbidity are still limited. This study presents the quality indicators on morbidity after surgical treatment for non-metastatic skin melanoma in an Italian registry.Methods: Data were extracted from the Central National Melanoma Registry (CNMR) promoted by the Italian Melanoma Intergroup (IMI). All surgical procedures (WE, SNLB or LFND) for non-metastatic skin melanoma between January 2011 and February 2017 were evaluated for inclusion in the study. Only centers with adequate completeness of information (>80%) were included in the study. Short-term complications (wound infection, dehiscence, skin graft failure and seroma) were investigated.Results: Wound infection rate was 1.1% (0.4% to 2.7%) in WE, 1.3% (0.7% to 2.5%) in SLNB and 4.1% (2.1% to 8.0%) in LFND. Wound dehiscence rate was 2.0% (0.8% to 5.1%) in WE, 0.9% (0.2% to 3.0%) in SLNB and 2.8% (0.9% to 8.6%) in LFND. Seroma rate was 4.2% (1.5% to 11.1%) in SLNB and 15.1% (4.6% to 39.9%) in LFND. Unreliable information was found on skin graft failure. Conclusions: Our findings contribute to available literature in setting up the recommended standards for melanoma centers, thus improving the quality of surgery offered to patients. A consensus on the core issues around surgical morbidity is needed to provide practical guidance on morbidity prevention and management.

show abstract

Measuring the quality of melanoma surgery – Highlighting issues with standardization and quality assurance of care in surgical oncology

Cited by 23 publications

References 94 publications

ECCO essential requirements for quality cancer care for melanoma: Defining how to organise care

ECCO essential requirements for quality cancer care for melanoma: Defining how to organise care

The Surgical Treatment of Non-Metastatic Melanoma in a Multicenter Registry: A Retrospective Cohort Quality Improvement Study to Reduce the Morbidity Rates

The surgical treatment of non metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): a retrospective cohort quality improvement study to reduce the morbidity rates

Contact Info

Product

Resources

About